BARCLAYS PLC - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 35 filers reported holding ACER THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$24,000
-83.3%
7,737
-85.9%
0.00%
Q4 2020$144,000
-10.0%
55,057
-1.0%
0.00%
Q3 2020$160,000
-50.6%
55,602
-41.2%
0.00%
Q2 2020$324,000
+72.3%
94,573
-0.2%
0.00%
Q1 2020$188,000
-52.2%
94,800
-3.4%
0.00%
Q4 2019$393,000
+28.9%
98,156
+2.6%
0.00%
Q3 2019$305,000
+67.6%
95,654
+105.1%
0.00%
Q2 2019$182,000
-83.2%
46,631
+4.8%
0.00%
-100.0%
Q1 2019$1,081,000
+116.6%
44,496
+79.4%
0.00%
Q4 2018$499,00024,8000.00%
Other shareholders
ACER THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Nantahala Capital Management 1,136,416$1,049,3670.10%
Anson Funds Management LP 129,795$119,8530.02%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 60,000$550.01%
Hudson Bay Capital Management LP 274,300$253,2890.00%
UBS Group AG 33$300.00%
RHUMBLINE ADVISERS 347$3200.00%
OSAIC HOLDINGS, INC. 200$1840.00%
WELLS FARGO & COMPANY/MN 132$1220.00%
NORTHERN TRUST CORP 22,231$20,5280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ACER THERAPEUTICS INC shareholders